|
26 May 2007 |
Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza
|
|
26 May 2007 |
MedImmune Receives Correspondence From FDA Regarding FluMist(R)
|
|
25 May 2007 |
Cytos Biotechnology reports results from a phase I/IIa study
|
|
25 May 2007 |
Celldex Therapeutics Initiates a Definitive Phase 2/3 Clinical Trial of CDX- 110 in Patients with Glioblastoma Multiforme
|
|
24 May 2007 |
VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
|
|
23 May 2007 |
Enzo Biochem Individualized Oral Immune Regulation Therapy
|
|
22 May 2007 |
Genitope Corporation Initiates Clinical Trial to Evaluate Use of MyVax(R) Personalized Immunotherapy Following Treatment With Rituximab and Chemotherapy for Follicular Non-Hodgkin's Lymphoma
|
|
19 May 2007 |
AVANT's Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
|
|
18 May 2007 |
Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of Tovaxin(TM) for Treatment of Multiple Sclerosis
|
|
18 May 2007 |
Data Published in The Lancet Show GARDASIL(R) was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
|
|
18 May 2007 |
Staphylococcus aureus vaccine development on track - safe and immunogenic in Phase I clinical trials
|
|
18 May 2007 |
Acambis' ACAM2000 receives positive recommendations from Advisory Committee
|
|
17 May 2007 |
Next Generation Nasal Spray Against Influenza: Clinical Phase I Study Started With FLUVACCdelNS1
|
|
16 May 2007 |
Cytos Biotechnology reports positive results from placebo controlled phase IIa study in patients suffering from house dust mite allergy
|
|
16 May 2007 |
In a phase II clinical trial, Curalogic has shown that its grass product is well tolerated without up-dosing
|
|
15 May 2007 |
Vical DNA Vaccine Elicits Lasting Memory T-cell Immune Responses in Humans
|
|
12 May 2007 |
Crucell, AERAS and SATVI Announce Start of Tuberculosis Vaccine Clinical Trial in South Africa six months after launching initial trial in the United States
|
|
12 May 2007 |
Phase I Trial for ImmunoCellular Therapeutics Brain Tumor Vaccine Commences
|
|
10 May 2007 |
Dendreon Receives Complete Response Letter from FDA For Provenge(R) Biologics License Application
|
|
10 May 2007 |
Cell Genesys Provides Update on Clinical Program for GVAX Immunotherapy for Leukemia
|
|
10 May 2007 |
Sinovac Commences Phase II Clinical Trials for Pandemic Influenza Vaccine (H5N1)
|
|
09 May 2007 |
Focetria(R), the Novartis pandemic influenza vaccine, receives European Union approval
|
|
04 May 2007 |
Pharmexa starts pivotal phase III trial in the United States
|
|
04 May 2007 |
BioMS Medical Completes Patient Recruitment in MINDSET-01 Phase II Relapsing-Remitting Multiple Sclerosis Trial
|
|
04 May 2007 |
Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
|
